Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
Psychopharmacol Bull. 2024 Jul 8;54(3):97-99. ABSTRACT NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in …